Coxibs: can this class of drugs survive?
- PMID: 17319092
- PMCID: PMC1993934
- DOI: 10.2147/vhrm.1.1.5.58931
Coxibs: can this class of drugs survive?
References
-
- Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 2000;343:1520–8. - PubMed
-
- Brock TG, McNish RW, Peters-Golden M. Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2. J Biol Chem. 1999;274:11660–6. - PubMed
-
- Catella-Lawson F. Vascular biology of thrombosis. Neurology. 2001;57(Suppl 2):S5–7. - PubMed
-
- Catella-Lawson F, McAdam B, Morrison BW, et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther. 1999;289:735–41. - PubMed
-
- Clark DWJ, Layton D, Shakir SAW. Do some inhibitors of COX-2 increase the risk of thromboembolic events? Drug Saf. 2004;27:427–56. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
